MedPath

The effect of remifentanil - thiopental sodium on cognitive impairment after electroconvulsive therapy

Not Applicable
Conditions
Patient with psychiatric disorder.
Mental and behavioural disorders due to psychoactive substance use,Schizophrenia, schizotypal and delusional disorders,Mood [affective] disorders
F10-39
Registration Number
IRCT201306086280N2
Lead Sponsor
Guilan University of Medical Sciences,Research and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

patients with psychiatric disorders diagnosed by psychiatrists according to DSMIV-TR criteria; age between 18-60 years old; signing informed consent; ASA physical status I or II; ECT candidates for the first time.
Exclusion criteria: emergency ECT; severe cognitive dysfunction prior to ECT; history of mental retardation; severe heart disease; history of previous ECT; ASA physical status III-IV; uncontrolled hypertension and needs to treat agitation after ECT.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of cognitive impairment after electroconvulsive therapy in general anesthesia with remifentani plus thiopental sudium. Timepoint: Before ECT, 5 hours and 24 hours after ECT. Method of measurement: By testing mini mental status exam (MMSE).;Severity of cognitive impairment after electroconvulsive therapy in general anesthesia with remifentani plus thiopental sudium. Timepoint: Before ECT, 5 hours and 24 hours after ECT. Method of measurement: By testing mini mental status exam (MMSE).
Secondary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before induction of anesthesia, immediately after ECT, after entering the recovery. Method of measurement: By electronic sphygmomanometer in the ECT room.;Heart rate. Timepoint: Before induction of anesthesia, immediately after ECT, after entering the recovery. Method of measurement: By monitoring heart rate.
© Copyright 2025. All Rights Reserved by MedPath